These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 329328

  • 1. Dosage and side effect comparisons betweel oral and depot fluphenazine.
    Schooler NR, Levine J.
    Psychopharmacol Bull; 1977 Jul; 13(3):29-31. PubMed ID: 329328
    [No Abstract] [Full Text] [Related]

  • 2. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR, Levine J.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [Abstract] [Full Text] [Related]

  • 3. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R.
    Adv Biochem Psychopharmacol; 1980 Jul; 24():483-93. PubMed ID: 6996445
    [No Abstract] [Full Text] [Related]

  • 4. Long-acting phenothiazines for treatment of schizophrenia.
    Med Lett Drugs Ther; 1976 Jan 16; 18(2):6-7. PubMed ID: 1107791
    [No Abstract] [Full Text] [Related]

  • 5. [Schizophrenia and its treatment].
    Fünfgeld EW, Kulhanek F.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1979 Jan 16; 7(3):169-80. PubMed ID: 382761
    [No Abstract] [Full Text] [Related]

  • 6. A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics.
    Quitkin F, Rifkin A, Klein DF.
    Psychopharmacol Bull; 1977 Jul 16; 13(3):27-9. PubMed ID: 329327
    [No Abstract] [Full Text] [Related]

  • 7. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May 16; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 8. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR, Levine J, Severe JB.
    Psychopharmacol Bull; 1979 Apr 16; 15(2):44-7. PubMed ID: 373006
    [No Abstract] [Full Text] [Related]

  • 9. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug 16; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 10. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
    Friemert K, Beier R, Vehreschild T.
    Psychiatr Neurol Med Psychol (Leipz); 1974 Jun 16; 26(6):374-7. PubMed ID: 4849639
    [No Abstract] [Full Text] [Related]

  • 11. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May 16; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 12. [Depot fluphenazine as a means of stabilizing remission in cases of schizophrenia].
    Vovin RIa, Vovina EN.
    Psychiatr Neurol Med Psychol Beih; 1975 May 16; 20-21():183-7. PubMed ID: 829620
    [Abstract] [Full Text] [Related]

  • 13. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI, Barron A, Kiriakos R.
    J Clin Psychopharmacol; 1983 Dec 16; 3(6):359-62. PubMed ID: 6139394
    [No Abstract] [Full Text] [Related]

  • 14. Depot fluphenazine in the treatment of psychosis in a community mental health clinic.
    Bucci L, Fuchs M, Simeon J, Fink M.
    Dis Nerv Syst; 1970 Sep 16; 31():Suppl:28-31. PubMed ID: 4920311
    [No Abstract] [Full Text] [Related]

  • 15. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH, Gelder MG.
    Adv Biochem Psychopharmacol; 1980 Sep 16; 24():599-602. PubMed ID: 7405678
    [No Abstract] [Full Text] [Related]

  • 16. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa, Minsker EI, Panteleeva GP, Mazurskii MB, Pekunova LG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Sep 16; 73(5):753-8. PubMed ID: 4718619
    [No Abstract] [Full Text] [Related]

  • 17. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 18. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug 29; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 19. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
    Johnson DA.
    Br J Hosp Med; 1977 Jun 29; 17(6):546-58. PubMed ID: 18242
    [No Abstract] [Full Text] [Related]

  • 20. [Importance of depot neuroleptics in psychiatry].
    Arató M, Erdös A.
    Orv Hetil; 1977 Oct 09; 118(41):2453-6. PubMed ID: 335322
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.